Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 814-509-8 | CAS number: 62132-67-6
Toxicological Summary
Administrative data
Workers - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 60 mg/m³
- Most sensitive endpoint:
- acute toxicity
DNEL related information
- Overall assessment factor (AF):
- 3
- Modified dose descriptor starting point:
- NOAEC
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Workers - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
Workers - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- no hazard identified
Additional information - workers
Poly alpha olefins and their respective structural analogues were not acutely toxic when administered via oral or dermal routes in several animal studies. Hence, these substances do not meet the classification and labelling criteria for acute oral or dermal toxicants as defined by EU DSD/DPD 67/548/EEC or CLP EU Regulation 1272/2008 (GHS aligned) criteria; therefore DNELs were not derived for these endpoints.
The available acute inhalation toxicity data indicate that some poly alpha olefins (viscosity <15 cSt at 40°C, average carbon number <C-30) are acutely toxic in experimental animal studies with inhalation LC50 values consistent with EU labelling requirements for Xn/R20 (Directive 67/548 EEC) or Acute Tox. 4, H332 (Regulation 1272/2008); a DNEL is required for substances meeting these physico-chemical criteria or where experimental data indicate a LC50 below 5 mg/L. However test data available for other samples with kinematic viscosity >15 cSt at 40°C and an average C-number of 30 or higher return LC50 values in excess of 5 mg/L; no classification or DNEL is required for these substances.
The reported LC50 for dec-1-ene, dimers, hydrogenated is below 5 mg/L and it is therefore classified as R20, Harmful if inhaled in accordance with EU Dangerous Substance Directive 67/548/EEC and as a Category 4 inhalation hazard under EU CLP regulation 1272/2008 (GHS aligned). Derivation of acute inhalation DNELs for dec-1-ene, dimers, hydrogenated are discussed below under the Worker Acute Inhalation DNEL and General Population Acute Inhalation DNEL section.
Regulatory classification and labeling for aspiration toxicity relies on the measured or calculated kinematic viscosity of a substance at 40°C rather than results from toxicological studies with animals. The reported kinematic viscosity value for dec-1-ene dimers, hydrogenated is 5.1 cSt (Chevron Phillips Chemical Company, 2002). This value meets the criteria for classification as an aspiration toxicant under DSD (< 7 cSt) and EU CLP (< 20.5 cSt) regulations. Dec-1-ene dimers, hydrogenated is classified as Xn, R65, Harmful in accordance with EU Dangerous Substance Directive 67/548/EEC and as a Category 1 aspiration toxicant under EU CLP regulation 1272/2008 (GHS aligned). A DNEL is neither feasible nor appropriate for this endpoint.
A one-generation reproductive toxicity study in which Alkane 4 (a structural analogue to 1-decene trimer, hydrogenated and trimers) was administered via oral gavage to rats showed no adverse effects on fertility or development at the highest dose tested of 1000 mg/kg bw/day (Knox et al., 2007). Additionally, rats exposed to Ethylflo 166 (1-decene homopolymer hydrogenated) in utero were again treated with Ethyflo 166 for an additional 91 days beginning 22 days after birth (Daniel, 1994). There were no treatment-related effects reported at the highest dose tested (1000 mg/kg bw/day) in the parental generation, offspring at birth, or following 91 days of subsequent oral exposure. The weight of evidence presented by these studies suggests that poly alpha olefins, as a group, are unlikely to present a significant hazard potential to fertility and development; therefore no DNEL for reproductive toxicity is necessary.
Worker Acute Inhalation DNEL
Information from studies using dec-1-ene dimer, hydrogenated, (summarised above) will form the basis for the DNEL. This indicates the occurrence of low levels of mortality in rats exposed for 4 hr to respirable concentrations of 0.76-1.81 mg/L test substance relative to an LC50 of 1.17 mg/L. Although the precise shape of the dose response curve at lower exposures is not known, it is not unreasonable to assume that no mortality would occur following exposure to respirable concentrations that were 10-fold lower.
An estimated NOAEC of 0.1 mg/L is therefore assumed for the acute inhalation toxicity of low molecular weight, low viscosity poly alpha olefins.
Modification of dose descriptor
Modify for differences in respiratory function for humans at rest and humans undertaking light work (following REACH TGD Chapter 8, Example A2) e.g.
Corrected NOAEC = 0.1 mg/L x 6.7/10 m3= 0.067 mg/L
Derive the Haber’s constant using the 4 hr data (using the corrected NOAEC of 0.067 mg/L) and the default regression coefficient (n) value of 3):
(c^n) x t = k
(0.067^3) x 4 = 1.20 x 10-3mg/L
Rearrange the modified Haber's law calculation and use the constant value to derive a concentration for the 15 minute (0.25 hour) time period:-
(c^n) x t = k
c = 3√ (k / t)
c = 3√ (1.20 x 10-3/ 0.25)
c = 0.1687 mg/L
The duration of exposure is appropriate for the assessment of human peak exposures.
Assessment factors1
Uncertainty | AF | Justification |
Interspecies differences | 1 | Default (inhalation) |
Intraspecies differences | 3 | Default (worker) |
Establishment of NOAEC | 1 | Default (note: 10-fold adjustment applied already) |
Duration of exposure | 1 | Default |
Overall AF | 3 |
|
1Assessment factors were based on ECETOC (2003)
DNELacuteInhalation: 0.1687 mg/L / 3 = 0.06 mg/L (60 mg/m3), 15 min TWA (worker)
General Population - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 50 mg/m³
- Most sensitive endpoint:
- acute toxicity
DNEL related information
- Overall assessment factor (AF):
- 5
- Modified dose descriptor starting point:
- NOAEC
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
General Population - Hazard via oral route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- no hazard identified
Additional information - General Population
General Population Acute Inhalation DNEL
Dose descriptor
Information from studies performed using dec-1 -ene, dimers, hydrogenated indicates the occurrence of low levels of mortality in rats exposed for 4 hr to respirable concentrations of 0.76-1.81 mg/L test substance relative to an LC50 of 1.17 mg/L. Although the precise shape of the dose response curve at lower exposures is not known, it is not unreasonable to assume that no mortality would occur following exposure to respirable concentrations that were 10-fold lower.
A estimated NOAEC of 0.1 mg/L is therefore assumed for the acute inhalation toxicity of low molecular weight, low viscosity poly alpha olefins.
Modification of dose descriptor
Derive the Haber’s constant using the 4 hr data (using the NOAEC of 0.10 mg/L and the default regression coefficient (n) value of 3):
(c^n) x t = k
(0.10^3) x 4 = 4.00 x 10-3mg/L
Rearrange the modified Haber's law calculation and use the constant value to derive a concentration for the 15 minute (0.25 hour) time period: -
(c^n) x t = k
c = 3√ (k / t)
c = 3√ (4.00 x 10-3/ 0.25)
c = 0.2520 mg/L
The duration of exposure is appropriate for the assessment of human peak exposures.
Assessment factors1
Uncertainty | AF |
Justification | |||
Interspecies differences | 1 | Default (inhalation) | |||
Intraspecies differences | 5 | Default (general population) | |||
Establishment of NOAEC | 1 | Default (note: 10-fold adjustment applied already) | |||
Duration of exposure | 1 | Default | |||
Overall AF | 5 |
|
1Assessment factors were based on ECETOC (2003)
DNELacuteInhalation: 0.2520 mg/L / 5 = 0.05 mg/L (50 mg/m3), 15 min TWA (consumer)
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Route: .live2